Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets

Clinical trial NCT05637541 · COMPLETED

Trial details

NCT number: NCT05637541
Sponsor: Fujian Akeylink Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis b

Start date: 2023-01-03
Primary completion: 2024-07-24
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.